Infectious Diseases and Clinical Microbiology

Prof. Dr. İmran Hasanoğlu

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
COVID-19Hemorrhagic Fever, CrimeanCross InfectionPneumonia, ViralCoronavirus InfectionsCommunicable DiseasesHIV InfectionsFever of Unknown Origin
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

The CV on this page was translated automatically from its original language. See the original

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 25 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Hemorrhagic Fever, Crimean 7 publications
  • Cross Infection 3 publications
  • Pneumonia, Viral 3 publications
  • Coronavirus Infections 3 publications
  • Communicable Diseases 2 publications
  • HIV Infections 2 publications
  • Fever of Unknown Origin 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
  • Department name at the sourceEnfeksiyon Hastalıklarısaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 25 publications · Model version —From source
  • Publications169 publicationsEurope PMC, OpenAlex, ORCIDFrom source
  • ORCID0000-0001-6692-3893ORCIDFrom source
  • Last synchronised7 November 2026 00:02https://ankarasehir.saglik.gov.tr/TR-328006/enfeksiyon-hastaliklari-klinigi-doktorlarimiz.html#imran-hasanoglusaglik.gov.tr

Scientific work

Publications on COVID-19

169 publications
Publications by year Most: 24, in 2022
  1. 2010: 3 publications
  2. 2011: 2 publications
  3. 2012: 1 publication
  4. 2013: 3 publications
  5. 2014: 5 publications
  6. 2015: 2 publications
  7. 2016: 9 publications
  8. 2017: 17 publications
  9. 2018: 19 publications
  10. 2019: 2 publications
  11. 2020: 17 publications
  12. 2021: 21 publications
  13. 2022: 24 publications
  14. 2023: 9 publications
  15. 2024: 18 publications
  16. 2025: 8 publications
  17. 2026: 9 publications

  1. Pyogenic psoas abscess: clinical profiles, imaging features, and outcomes in a retrospective single-center study of 32 cases

    BMC infectious diseases, 2026

    DOI 10.1186/s12879-026-12666-3 PMID 41735915 Open-access full textSource: Europe PMC

  2. Neurocognitive and neuropsychiatric evaluation of individuals living with HIV compared to HIV uninfected individuals

    AIDS care, 2026

    DOI 10.1080/09540121.2025.2594611 PMID 41332418 1 citation (Europe PMC) Source: Europe PMC

  3. Impact of Advanced Age on Posttransplant Infections and Outcomes in Solid Organ Transplant Recipients: A Multicenter Cohort Study

    Transplant infectious disease : an official journal of the Transplantation Society, 2026

    DOI 10.1111/tid.70232 PMID 42089790 Open-access full textSource: Europe PMC

  4. Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis

    Minerva Gastroenterology, 2026

    DOI 10.23736/s2724-5985.26.03992-6 PMID 41848668 1 citation (OpenAlex) Source: OpenAlex

  5. Are we testing rationally? a two-year evaluation of repeat anti-HIV screening in a tertiary hospital

    AYBU AVESIS, 2026

    Source: OpenAlex

  6. Are we screening or wasting? The hidden burden of repeat Anti-HCV testing in the hepatitis elimination era

    AYBU AVESIS, 2026

    Source: OpenAlex

  7. Impact of the expanded program on immunization on Hepatitis B elimination efforts: Insights from a Turkish reference center

    AYBU AVESIS, 2026

    Source: OpenAlex

  8. Diagnosis, management, and prevention of Crimean-Congo haemorrhagic fever: a Delphi-based consensus study in Türkiye

    EClinicalMedicine, 2026

    DOI 10.1016/j.eclinm.2026.104156 PMID 42633390 Open-access full textSource: OpenAlex

  9. Clinical management, antifungal susceptibility, and predictors of 28-day mortality in Candidozyma auris candidemia: A single-center cohort study

    Medical Mycology, 2026

    DOI 10.1093/mmy/myag105 PMID 42788966 Open-access full textSource: OpenAlex

  10. Monitoring of Patients Receiving Immunosuppressive and Biological Agent Treatments for Infectious Complications

    Infectious Diseases and Clinical Microbiology, 2025

    DOI 10.36519/idcm.2025.547 PMID 41111489 Open-access full textSource: ORCID

View all 169 publications